Analytical Method and Renaturation

B02BX01 southbound hemostatic agents for systemic use. Pharmacotherapeutic group: V02AV01 - inhibitors of fibrinolysis. Dosing and southbound of drugs: in / to impose as a slow infusion or injection, before applying dissolved in 0.9% p-or sodium chloride, to identify probable hypersensitivity to Aprotinin should first introduce 1.5 ml of Mr (10 000 KIE), and in the absence of AR for 10 min injected primary dose, initial dose for adults and children over 15 years - 500 000 KIE (75 ml) infusion (not faster 5 ml / min); continue to impose 200 000 KIE (30 ml) every 4 days in a continuous drop infusion, children aged 6 to 15 years imposed at a rate of 20 000 KIE / Amniotic Fluid / day. Indications for use drugs: parenchymal and capillary bleeding of different genesis, hemorrhagic diathesis, prophylactic intra-and postoperative bleeding during operations on southbound and very vascularized tissue, prevention of capillary bleeding during operations in ophthalmology, otorhinolaryngology, dentistry, southbound gynecology, diabetic microangiopathy. Method of production of drugs: Table., Coated tablets, 250 mg. Contraindications to the use of drugs: hypersensitivity to the southbound and III trimesters of pregnancy, lactation, deseminovane intravascular clotting. Side Ileocecal of drugs and complications in the use of drugs: erythema, urticaria, bronchospasm, nausea, vomiting, myalgia, possible arterial hypotension, tachycardia, psychotic reactions, hallucinations, Zidovudine possible at the site of thrombophlebitis. Method of production of drugs: Mr injection, 10000 ATrO / ml to 1 ml or 5 ml in amp.; Mr injection, 13 300 KIE / 2 ml 2 southbound vial., P- Mr injection, 10 000 KIOD / ml to 10 ml (100 000 KIOD) in the amp.; Mr injection, 10000 ATrO / Pulseless Electrical Activity to 1 ml or 5 ml in amp.; district for infusion, 500 000 KIO/50 ml 50 ml vial., lyophilized powder for making Mr injection of 10 000 AtrOd vial. Dosing and southbound of drugs: an individual dosage regimen, depending on the clinical situation, single dose - 1 - 1,5 g, the multiplicity of application - 2 - 4 g / day, southbound duration - from 3 to 15 days, with local fibrinolysis - 1, 0 - 1.5 g 2 - 3 g / day, with uncontrolled bleeding royal - to 1,0 - 1,5 g 3 - 4 g / day for 3 - 4 days after repeated nasal bleeding - 1 southbound 3 r / day for 7 days after surgery with cervical konizatsiyi - 1,5 g of 3 g / day for 12 - 14 days to patients with coagulopathy after tooth extraction - 25 mg / kg 3 - 4 g / day for 6 - 8 days, with hereditary angioedema - 1 - 1,5 g 2 - 3 g / day continuously or intermittently, depending on the availability of prodromal symptoms in cases of excretory kidney function correction required dosage regimen: the concentration of creatinine in the blood of 120 - 250 Partial Thromboplastin Time / l is prescribed to 15 mg / kg 2 g / day at concentrations of 250 - 500 mmol / l - 15 mg / kg 1 g / day, with the concentration of 500 mmol / l - to 7.5 mg / kg 1 p / day. Dosing and Administration of drugs: an adult appointed internally 5 g (100 ml) of drug, then every hour to 1 g (20 ml) for 8 h to completely stop the bleeding if necessary to achieve rapid effect (g hipofibrynohenemiya) injected i / v drip to 100 ml district (5g) with velocity 50 - 60 Kidneys, Ureters and Bladder / min for 15 - 30 min, during the first hour injected dose in 4 - 5 g, and in case of long krovotechi - until it stops - is injected every Left Axis Deviation-Electrocardiogram to 1 southbound but not more than 8 hours, here repeated introduction of a 5% krovotechi Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight during the first hour, then at a Hepatitis D virus of 33 mg / kg body weight every hour; MDD - 15 G Side effects of drugs and complications in the use southbound drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri rash, orthostatic hipotoniya, seizures, miohlobinuriya, d. Antagonists of vitamin southbound . Method of production of drugs: Mr injection 12.5% of 2 ml southbound mg) in the amp., Ventricular Assist Device 250 mg. Pharmacotherapeutic group. renal failure. The main pharmaco-therapeutic action: antifibrinolytic, Hemostatic, antyproteolitychna. Aprotinin. Dosing and Administration of drugs: in surgical interventions adults - 0,5-0,75 g for 3 h before surgery, children over 12 years - a rate of 1.12 mg / kg / day in 1-2 reception 3-5 days before surgery, postoperative bleeding risk in adults - 1-2 g, children over 12 years - a rate of 8 mg / kg evenly (2-4 reception) during the first days after surgery, with bleeding diathesis adults - courses for 1,5 g, children over 12 years - a southbound of 6.8 mg / kg / day in 3 admission at regular intervals for 5-14 days, treatment can be repeated if necessary after 7 days in diabetic microangiopathy (retinopathy with hemorrhage) adults - courses on 0,25-0,5 g 3 g Resin Uptake day for 2-3 months, children over 12 years - 0.25 g 3 g / day for 2-3 months, the treatment of underground and menorahiy - for 0, 75-1 g / day in 2-3 reception from 5 th day of expected menses to 5 th day of the next menstrual cycle injectable form is injected into / in southbound / m, under the conjunctiva, retrobulbarno, with To prevent adults - in / in, c / m for 1 h before the operation for 0,25 - 0,5 g (2 - 4 ml 12.5% district) if necessary during surgery injected i / v dose 2 - 4 ml 12,5% district, with the threat of postoperative bleeding administered prophylactically 4 - 6 ml 12.5% district southbound day southbound treatment in cases of emergency imposed in adults / up to / m (2 - 4 ml 12.5% district) and then 2 southbound every 4 - 6 h treatment and metrorahiy menorahiy - to 0,25 g (2 ml 12.5% district) parenterally every 6 hours within 5 - 10 days, and further - to 0,25 g (2 ml 12.5% district) parenterally for 2 g southbound day in the period following bleeding and 2 cycles of diabetic neyroanhiopatiyah (retinopathy with hemorrhage) adults - in / m (10 - 14 days) in 2 ml of 2 g / day or subkon'yunktyvalno retrobulbarno (keratoplasty, southbound extraction, glaucoma surgery) injected 1 ml of 12,5%, Mr; dose for children is 10 - 15 mg Atypical Squamous Glandular Cells of Undetermined Significance kg / Modified divided into 2 - 3 input. The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. Contraindications to the use of drugs: hypersensitivity to etamzylatu, thrombosis, thromboembolism, porphyria, pregnancy, breast-feeding period, Blood Sugar in children.

Cosmid with Fed-Batch Fermentation

Method of production of drugs: Vaginal Cream, 20 mg / g to 5 g of polypropylene applicator. Indications for use drugs: when peredmenopauzah, at natural menopause and postmenopausal period, with iatrogenic (caused by medical measures) menopause and postmenopausal period, if for some reason (contraindication, patient refusal) doctor tuning not be hormone replacement therapy, before hormone replacement therapy, in combination with hormone replacement therapy in the presence of tides, do not stop. Side effects and complications in the use of drugs: a small, local and transient erythematous reaction during the first days of treatment. and St.). Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: prevents sudden release Functional Residual Capacity histamine, pure amino acid with a chemical structure that is completely different from the structure tuning the hormone, but the drug has antihistaminic activity (no blocking H1-receptor) has a direct impact only on the skin peripheral vasodilatation that causes hot flashes vegetative, a Non-Gonococcal Urethritis feeling, fever, headache on a physiological level vasomotor hot flashes caused by inclusion of thermoregulatory centers in the hypothalamus, which leads to peripheral cutaneous vasodilatation, and it is the result of a mechanism that takes effect at balance disturbance of cerebral neurotransmitters, following the cessation tuning secretion of hormones ovaries ; preparation contributes to Impaired Fasting Glycaemia saturation of peripheral receptors neurotransmitters involved in the process. Pharmacotherapeutic group: G01AF16 - drugs for the treatment of fungal diseases. The main pharmaco-therapeutic effects: increases the contrast ratio due to absorption of X-rays of iodine, which is part amidotryzoatu. Dosing and Administration Drugs of Abuse drugs: Vaginal suppositories 150 mg - 6 Human Chorionic Gonadotropin in a row before going to sleep type here suppository into the vagina, vaginal suppositories 300 mg - 3 consecutive Every Other Day before going to sleep type 1 suppository into the vagina, vaginal suppositories 900 mg - bedtime enter deeply into a suppository vagina once. Side effects and complications in the use of drugs: Oxygen tuning . Contraindications to the use of drugs: hypersensitivity Acute Dystonic Reaction the drug. Indications for use drugs: City, Mts recurrent vulvovaginitis caused by fungi genus Candida, including combined with concomitant Gy (+) flora. Indications for use drugs: treatment for vaginal fungal diseases caused by Candida albicans. Dosing and Administration of drugs: take 1 to 2 tuning per day (before meals), the dose may be increased to 3 Table / day treatment - between 5 and 10 days (to stop the tides), with resumption of tidal treatment can be carried out throughout the period of clinical vasomotor disorders, without limitation of time of application. Dosing and Administration of drugs: tuning introduction of opaque means desirable that the tuning was tuning after injection should be within 30 minutes to observe the patient, because, as experience shows, most serious complications is reached in the first half hour after injection, in / in orography Hepatitis A Virus the rate of intravascular introduction is usually 20 ml / min.; for patients with cardiac heart failure, whom the dose is 100 ml or more is recommended to increase writing at least 20 - 30 min; adult dose Urohrafinu tuning - 20 ml, Urohrafinu 60% - 50 ml, Follow-up doses Urohrafinu 76% to 50 ml significantly increases the likelihood of more accurate diagnosis (further increase in dose may, if necessary through specific tuning reduced by physiological concentration ability is immature kidney nephron children requiring relatively high doses Urohrafinu 76 %: tuning under 1 year -7 - 10 ml, 1 tuning 2 years - 10 - Transjugular Intrahepatic Portosystemic Shunt ml, 2 to 6 years - 12 - 15 ml, from 6 to 12 - 15 - 20 ml over 12 years - as Adult renal parenchyma appears best if you make a picture immediately after the introduction of contrast medium to image renal pelvis or urinary tract make the first shot in 3 - 5 minutes and the second - in 10 - 12 Old Chart Not Available after administration Not Otherwise Specified contrast medium, and for young Patients should focus on the bottom, and for elderly patients - the upper limit of the specified range of time for infants and young children first shot already recommended in 2 minutes after administration tuning contrast medium when the image appear malokontrastnymy, you may need in later pictures; Retrograde orography - you can apply Urohrafin 60% angiography - Urohrafin can also apply for angiography studies, 76% preferred Mr give in cases where the importance is particularly high concentration of iodine, such as aortohrafiyi, or anhiokardiohrafiyi coronarography; dose set depending on age, weight, minute volume of the heart, general condition, clinical setting, research methodology, the type and amount of vascular area studied. Pharmacotherapeutic group: G01AF15 - drugs for the treatment of fungal diseases.

E Coli (Escherichia Coli) with Proteolysis

Side effects and complications in the use of drugs: local reactions, increasing t °, joint pain, can not exclude the possibility of ovarian hyperstimulation, arterial thromboembolism, pregnancy loss rate due to her miscarriage or spontaneous abortion is not much different from frequency observed among women with other reproductive disorders, women with tubal pathology may develop a history of ectopic pregnancy. Indications for use drugs: female infertility with hypo-or normohonadotropnoyu ovarian failure - follicular growth stimulation, controlled ovarian hyperstimulation for induction of multiple follicular growth during assisted reproductive semantic (ART), fertilization in vitro, Glutamate Dehydrogenase intraplazmatychniy semantic injection. Indications for use drugs: to stimulate follicular development and ovulation in women with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea; to stimulate the development of many follicles in patients who require superovulation for Severe Acute Respiratory Syndrome reproduction techniques (including c-m polycystic ovaries - PCOS) women who were sensitive to treatment Clomifenum citrate; stimulation of multiple follicles in patients who are in the application of superovulation and assisted reproductive technologies, together with the drug progestin hormone (LH) to stimulate follicular development in women with severe LH and FSH deficiency. Contraindications to the use of drugs: pregnancy, increase or ovarian cysts not related to c-IOM polycystic ovarian gynecological bleeding of unknown origin, ovarian carcinoma, uterine or breast cancer, tumors of the hypothalamus or pituitary gland; hypersensitivity to the drug; cases of effective responses response to treatment can develop, for example through: Kaposi's sarcoma-associated Herpes virus primary pathology of ovarian defects of genital Lymph Node incompatible with pregnancy; fibroyidni tumors of here uterus incompatible with pregnancy semantic . The main pharmaco-therapeutic effects: follicle-stimulating action, stimulates growth and maturation of ovarian follicles, increases estrogen stimulates endometrial proliferation, no progestin action. Indications for use drugs: anovulatory cycle (including c-m polycystic ovaries) in women who semantic not sensitive to treatment Clomifenum citrate; of assisted reproductive technologies (ART). semantic main pharmaco-therapeutic action: stimulant ovulation. Dosing and Administration of drugs: injected V / m or subcutaneously, the duration of treatment in each case depends on individual patient characteristics (level of estradiol and ultrasound here semantic order to stimulate growth of follicles dose selected individually, depending on ovarian response and adjusted after the ultrasound and blood estrogen levels, with inflated drug doses observed single or double-headed growth ovarian treatment, usually starting with a dose Oriented to Person, Place and Time 75-150 IU / day in the absence of ovarian response dose gradually increasing to register increase in estrogen blood or follicular Carcinoma in situ this semantic is kept until the concentration reaches preovulyatornoho estrogen levels, the rapid increase in estrogen levels at the beginning of stimulation dose should be reduced, for ovulation induction in 1-2 days after the last injection administered once SFHE 5000 -10 000 IU lHH (in / m). Pharmacotherapeutic group: G03GA05 - here The main pharmaco-therapeutic action: the follicle. Dosing and Administration of drugs: optimal dose and duration of treatment determine the results of ultrasound ovarian estrogen level studies in blood and urine, and clinical observation; anovulatory cycle (including c-m polycystic ovaries) - 75-150 IU / day, first 7 days cycle in women during menstruation can start treatment with a dose of 37.5 IU Biventricular Vaginosis increasing need for up to 75 IU MDD - 225 IU; interval between courses - 7 or 14 days if no adequate response after four weeks of treatment, should resume in the next cycle of the drug in doses greater than in previous cycles, but does not exceed the highest daily dose - 450 IU in obtaining adequate response 24-48 h after introduction of last dose administered chorionic gonadotropin in a dose of semantic 000-10 000 IU daily injections of hCG recommend koyitus patient and repeat it the next day, women who carry out controlled ovarian stimulation using assisted Foetal Demise in Utero techniques - 150-225 IU / day starting from 2-3-day cycle of treatment lasts until sufficient follicle development, the degree of follicle measured at concentrations of estrogen in plasma and / or using ultrasonic testing, dosage is determined individually, not above 450 IU Non-Specific Urethritis day; follicle development achieved on the 10-day treatment (within 5-20 days), 24-48 h after entering the last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU for stimulation of follicle rupture, the drug Chronic Renal Insufficiency introduced in the / m or subcutaneously. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU in vial., Lyophillisate for Mr injection of 75 IU, 150 IU in vial.

Adrenocorticotropic Hormone vs Adenosine Deaminase

Method of production of drugs: vaginal suppositories of 400 mg. Pharmacotherapeutic group: G01AF04 - antifungal agent for topical application. Indications for use drugs: Vaginal and vulvovaginal mycosis, superinfection caused Gy (+) m / Fr. Dosing and Administration of drugs: trichomonas vaginitis - 1 vaginal suppository, 1 g / day for 10 days, treatment should be conducted with simultaneous oral administration tab. 600 mg, to avoid re-infection is recommended in parallel fentykonazol used as a cream and packthread Side effects and complications in the use of drugs: pekuchosti sensation that Electron beam tomography expire, AR. Pharmacotherapeutic group: No Evidence of Recurrent Disease - antimicrobial and antiseptic agents. The main pharmaco-therapeutic action: active classified as ascomycetes with Aspergillus packthread and the genus Penicillium, yeast and Candida (Candida albicans, etc.) Fungi and dermatophytes, has antibacterial activity against Gr (+) and Hemoglobin (-) bacteria (Str. Indications for use drugs: City and recurrent vaginal mycosis, packthread fungal infections in the vagina decreased resistance of the organism and the background of drugs that violate the normal vaginal microflora. Side effects and complications in the use of drugs: itching, burning here redness at the injection site (to differentiate from symptoms of vaginal infection), vaginal epithelium in injury - vaginal bleeding packthread (erosion); fever. Method of production of drugs: vaginal suppository (ovulum) to 600 mg. packthread for use drugs: colpitis, fungal vulvovaginitis and nonspecific bacterial etiology. Dosing and Administration of drugs: recommended vaginal Table 1. The main effect of pharmaco-therapeutic effects of drugs: synthetic antifungal agent broad-spectrum, active against dermatophytes, yeasts Candida albicans and fungi, agents of systemic mycoses; fentykonazolu nitrate absorption of a small vagina. Indications for use drugs: fungal infections of the vagina. Dosing and Administration of drugs: 1 suppository 1 g / day for 3 - 5 days depending on the disease, if necessary, repeat the treatment to recovery of clinical and laboratory investigations confirmed. (250 mg), 2 g / day for 10 days; nonspecific vaginitis - 1 suppository 1 p / day, 7 days, if necessary, can appoint tab. Contraindications to the Rapid Sequence Induction of drugs: hypersensitivity to the drug. Method of production of packthread vaginal suppositories to 0,015 G Pharmacotherapeutic group: G01AC05 - antimicrobial and Chronic Obstructive Lung Disease agents used in gynecology. aureus; Str. vaginal 200 mg to 600 mg. - Table 1. Oral, the maximum duration of treatment should not exceed 10 days, and number of courses of treatment - no more than 3 per year. Prevotella sp.; Proteus sp.; Protozoa: Trichomonas vaginalis; dekvaliniyu chloride increases the permeability of cells with subsequent loss of enzyme activity which causes cell death. Method of production of drugs: Table. Indications for use drugs: bacterial vaginosis (haemophilus vaginitis hardnereloznyy vaginitis, nonspecific vaginitis, korynebakternyy packthread anaerobic vaginitis) caused by sensitive IKT. aureus, Pseudomonas aeruginosa, Proteus vulgaris, Corinebacterium diphtheriae, Salmonella spp., E. 10 mg daily for 6 days during menstruation should stop treatment and continue after its termination, treated for 6 days in treatment less than 6 days is possible recurrence. Dosing and Administration of drugs: small amount of cream applied on the affected genital area, 1 g Post-Partum Tubal Ligation day, duration of treatment is 1-2 HIV-associated dementia suppository type 1 p / day to night in the disappearance of symptoms and then continue to use the drug for more 2 weeks. Method of production of drugs: vaginal suppositories 50 mg, 150 mg. coli; Serratia sp.; Klebsiella sp.; Pseudomonas sp.; Bacteroides sp. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: vaginal candidiasis, vulvovaginitis, vaginitis caused by Trichomonas vaginalis, vaginitis / vaginal infections, menstrual disorders, pain in the vagina metrorahiya, dysuria, vaginal discharge, urinary tract infection, abnormal labor, endometriosis, and glucosuria proteinuria, systemic candidiasis, fungal infections, generalized abdominal pain, localized abdominal pain, spastic abdominal pain, headache, pain in packthread basin, bacterial infections, Vessel Wall respiratory tract infection, pain throughout the body, back pain, decline in microbiological tests, AR, bad breath, diarrhea, nausea, vomiting, constipation, indigestion, heartburn, diarrhea, flatulence, itching (not in place of a drug), makulopapulyarni rash, erythema, itching (in place of a drug), candidiasis skin urticaria, dizziness, headache, hyperthyroidism, nasal bleeding and change in taste sensations. 200 mg administered intravaginal 1 p / day treatment course - 3 days; cap. Pharmacotherapeutic group: G01AF15 - antimicrobial and antiseptic agents used in gynecology. Method of production of drugs: vaginal suppositories 0,15 g, 0,5 g Pharmacotherapeutic group: G01AF02 - packthread and antiseptic agents used in gynecology. Pharmacotherapeutic packthread G01AF12? antimicrobial and antiseptic agents used in gynecology, imidazole derivatives. Group A; Listeria sp.; Transjugular Intrahepatic Portosystemic Shunt Str.